Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Hexagon Nutrition IPO
Price Band
₹42.0–45.0
Issue Size
₹138.87 Cr
Lot Size
333 shares
Min Investment
₹14,985
GMP
+₹2.75 (6.11%)
Issue Price
₹45.0
Hexagon Nutrition IPO AI Summary
- Hexagon Nutrition IPO is listed on BSE, NSE in the Pharmaceuticals sector.
- Price band: ₹42.0–₹45.0 per share, lot size 333 shares (min. investment ₹14,985).
- Subscription window: 05 Jun–09 Jun 2026, listing on 12 Jun 2026.
- Current GMP is +₹2.75 (6.11%), an estimated listing price of ₹48 — unofficial and can change daily.
Hexagon Nutrition Ltd. is set to launch its IPO with an issue price of ₹45.0, aiming to raise ₹138.87 Cr. The company has shown a positive trend in revenue and profit growth over recent periods, and it has a strong distribution network both domestically and internationally.
TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.
Important Dates
Subscription Status
Overall Subscription
1.65x
| Category | Subscription | Status |
|---|---|---|
| QIB (Institutional) |
0.00x
|
0.00x |
| NII (HNI) |
2.03x
|
2.03x |
| ↳ bNII (>₹10L) |
1.32x
|
1.32x |
| ↳ sNII (<₹10L) |
3.45x
|
3.45x |
| Retail (RII) |
2.43x
|
2.43x |
| Total | 1.65x | 1.65x |
Auto-updated every 5 min · As of 5th Jun 2026 17:08
Hexagon Nutrition IPO Grey Market Premium (GMP) Today
GMP
+₹2.75
GMP %
+6.11%
Est. Listing
₹47.75
Updated: 14 Jul 2026 15:51
About the Company
Hexagon Nutrition Ltd. is a research-focused nutrition company engaged in the development and manufacturing of micronutrient premixes, wellness and clinical nutrition products, therapeutic formulations, and ready-to-use nutritional foods. The company operates four manufacturing facilities, including three in India at Nasik (Maharashtra), Chennai (Tamil Nadu), and Thoothukudi (Tamil Nadu), and one overseas facility in Tashkent, Uzbekistan. The Chennai and Thoothukudi units are located in Special Economic Zones (SEZs), offering operational benefits such as port connectivity and access to duty-free imports. Its product portfolio is broadly divided into three categories: Branded wellness and clinical nutrition products serving the B2C segment Premix formulations catering to B2B2C customers Ready-to-Use Foods (RUFs) and Micronutrient Powders (MNPs) developed under its ESG-focused nutrition initiatives Hexagon Nutrition has built a PAN-India omnichannel distribution network that reaches customers through retail pharmacies, hospital networks, e-commerce platforms, online pharmacies, and its own branded websites, including Pentasure, Obesigo, Pediagold, and Nutrone. For domestic distribution, the company partners with over 342 distributors across India, including 8 distributors with multi-state operations. The company also maintains an international presence through offices in South Africa, Uzbekistan, and Hong Kong, supporting its global operations. Between fiscals 2023 and 2025, its products were exported to more than 75 countries across Asia, Africa, Europe, and South America.
Company Financials (₹ Cr)
As of 2025-12-31
| Period Ended | 31 Dec 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 327.60 | 261.36 | 250.54 | 288.90 |
| Total Income | 275.57 | 331.29 | 304.62 | 281.65 |
| Profit After Tax | 27.03 | 24.38 | 12.21 | 5.82 |
| EBITDA | 37.55 | 40.07 | 24.88 | 17.17 |
| NET Worth | 223.05 | 195.60 | 176.29 | 163.84 |
| Reserves and Surplus | 210.92 | 183.89 | 164.51 | 152.30 |
| Total Borrowing | 39.79 | 26.60 | 36.89 | 51.87 |
Key Ratios
EPS
₹1.98
NAV
₹15.91
ROE
10.47%
ROCE
17.06%
RoNW
12.46%
P/B Value
2.83
P/E Ratio
22.69
Market Cap
₹553.13 Cr
PAT Margin
7.36%
Debt/Equity
0.14
Promoters
Arun Purushottam Kelkar, Subhash Purushottam Kelkar, Vikram Arun Kelkar and Nikhil Arun Kelkar
IPO Evaluation
Generated 23 Sep 2026Revenue Trend
Total income was ₹281.65 Cr in the fiscal year ending 31 Mar 2023, increasing to ₹304.62 Cr by 31 Mar 2024, then rising further to ₹331.29 Cr by 31 Mar 2025. In the most recent period, total income was ₹275.57 Cr as of 31 Dec 2025, though this is a 9-month figure, not a full year, so isn't directly comparable.
Profit Trend
Profit after tax was ₹5.82 Cr in the fiscal year ending 31 Mar 2023, growing to ₹12.21 Cr by 31 Mar 2024, then increasing to ₹24.38 Cr by 31 Mar 2025. The most recent figure is ₹27.03 Cr as of 31 Dec 2025, though this is a 9-month figure, not a full year, so isn't directly comparable.
Grey Market Premium, Explained
The Grey Market Premium (GMP) indicates the expected listing price of an IPO based on unofficial trading before it officially lists on the stock exchange. A positive GMP suggests that the market anticipates a higher price than the issue price on listing day.
Subscription Demand
As of 5th June 2026, the IPO has been subscribed 1.65 times overall. The retail segment saw a subscription of 2.43 times, while the non-institutional investors (NII) segment was subscribed 2.03 times. The qualified institutional buyers (QIB) segment did not receive any bids.
Who This IPO Suits
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their overall portfolio strategy and risk tolerance. It's important to consider the company's growth potential and market conditions.
Who May Want to Wait
Investors with a low risk tolerance or those seeking immediate returns may want to avoid this IPO. It's essential to assess personal investment goals and market volatility before participating.
IPO Timeline, Explained
The IPO opens for subscription on 5th June 2026 and closes on 9th June 2026. Allotment of shares will be announced on 10th June 2026, and the shares are expected to be listed on the stock exchange on 12th June 2026.
Listing Gains — The Risk
Listing gains refer to the potential profit made when shares are sold on the listing day at a price higher than the issue price. However, there are risks involved, as market conditions can fluctuate, and there is no guarantee of immediate gains.
This evaluation is generated from Hexagon Nutrition's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.
Frequently Asked Questions
What is Hexagon Nutrition IPO GMP today?
Hexagon Nutrition IPO GMP today is +₹2.75 (6.11%), indicating an estimated listing price of ₹48. GMP is an unofficial grey-market indicator and can change daily.
What is the price band of Hexagon Nutrition IPO?
The price band of Hexagon Nutrition IPO is ₹42.0–₹45.0 per share.
When does Hexagon Nutrition IPO open and close?
Hexagon Nutrition IPO opens on 05 June 2026 and closes on 09 June 2026.
When does Hexagon Nutrition IPO list on the stock exchange?
Hexagon Nutrition IPO listed on 12 June 2026 at ₹47.75.
What is the lot size for Hexagon Nutrition IPO?
The lot size for Hexagon Nutrition IPO is 333 shares, requiring a minimum investment of ₹14,985.
What is the issue price of Hexagon Nutrition's IPO?
The issue price is ₹45.0.
What is the minimum investment required?
The minimum investment required is ₹14,985.0.
What is the lot size for this IPO?
The lot size is 333 shares.
When is the listing date for the IPO?
The listing date is 12th June 2026.
What does GMP mean?
GMP stands for Grey Market Premium, which indicates the expected listing price based on unofficial trading.
Issue Details
Investor Allocation
Registrar
Lead Managers / Book Running
IPO Timeline
Open
05 Jun 2026
Close
09 Jun 2026
Allotment
10 Jun 2026
Listing
12 Jun 2026
Similar IPOs in Pharmaceuticals
Plan Your IPO Investment
Related Articles
Community Sentiment
What are other investors planning for Hexagon Nutrition?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.